Discover Tenders by Non Leather Belts Sector

Find the most relevant tenders for Non Leather Belts. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Leather Belts tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Leather Belts tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V On Active Ingredients Medicines Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5901848

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Combination Dolutegravir I Rilpivirine Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864985

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Fosamprenavir Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864945

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pegvisomant Vv 77

Deadline: 10 May 2026

Germany

Ref. No.: 5864924

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Meiosis In Barley Mixing It Up

Deadline: 31 Jan 2026

Germany

Ref. No.: 5845917

EMD:Ref Document

Bid Value: Ref Document

81 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Blood Sugar Test Strips

Deadline: 10 May 2026

Germany

Ref. No.: 5837360

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Medicines With The Active Ingredient Rivaroxaban Atc B01Af01 In All Potencies Except 2 5 Mg Per Divided Oral Dosage Form

Deadline: 30 Apr 2026

Germany

Ref. No.: 5771252

EMD:Ref Document

Bid Value: Ref Document

170 Days Left

Medicines With The Active Ingredient Rivaroxaban Atc B01Af01 With A Potency Of 2 5 Mg Per Divided Oral Dosage Form

Deadline: 30 Apr 2026

Germany

Ref. No.: 5769473

EMD:Ref Document

Bid Value: Ref Document

170 Days Left

Medicines With The Active Ingredient Testosterone Atc G03Ba03 In The Dosage Form Injection Solution

Deadline: 30 Apr 2026

Germany

Ref. No.: 5762364

EMD:Ref Document

Bid Value: Ref Document

170 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5730369

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Lipegfilgrastim L03Aa14 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5729395

EMD:Ref Document

Bid Value: Ref Document

170 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Mebeverine A03Aa04 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5728537

EMD:Ref Document

Bid Value: Ref Document

170 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5727706

EMD:Ref Document

Bid Value: Ref Document

180 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ganirelix H01Cc01 Within The Framework Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5727688

EMD:Ref Document

Bid Value: Ref Document

170 Days Left

Showing 27541 to 27555 of 27823 results

‹
1
2
...
1834
1835
1836
1837
1838
1839
1840
...
1854
1855
›

Discover Tenders by Non Leather Belts Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Leather Belts Sector

Filter Your Search

FREE Trial plan for all new users!